View Clinical Trial (Medical Research Study)
Growth of Preterm Infants Consuming Formula
| City: |
|
Iowa City |
| State: |
|
Iowa |
| Zip Code: |
|
52241 |
| Conditions: |
|
Growth - Development - Infant |
| Purpose: |
|
The purpose of this study is to assess growth of preterm infants fed a test formula compared
to a standard formula up to the first 4 months of corrected gestational age.
|
| Study Summary: |
|
|
| Criteria: |
|
Inclusion Criteria:
- Born AGA
- Exclusively formula-fed
- 28-34 weeks GA at birth
- Intact GI tract, tolerating full oral feeds
- Expected to be discharged from the hospital within a minimum of 24 hours, maximum of
5 days
Exclusion Criteria:
- Severe respiratory disease defined as needing mechanical ventilation at discharge
- Any significant systemic diseases that could affect growth. This includes cardiac,
neurologic, or GI conditions.
- Major congenital malformation, history of GI surgery, severe postnatal complications
- Daily or routine diuretic use at time of discharge
- Receiving more than 10% of daily kcals from food additives such as thickeners
- Currently participating or having participated in another conflicting clinical trial.
|
| NCT ID: |
|
NCT01162798 |
| Primary Contact: |
|
Principal Investigator
Ekhard Ziegler, MD
University of Iowa
Ekhard Ziegler, MD
Phone: (319) 335-4570
Email: ekhard-ziegler@uiowa.edu
|
| Backup Contact: |
|
N/A |
| Location Contact: |
|
Iowa City, Iowa 52241
United States
There is no listed contact information for this specific location.
Site Status: Recruiting |
| Data Source: |
|
ClinicalTrials.gov |
| Date Processed: |
|
May 23, 2013 |
| Modifications to this listing: |
|
Only selected fields are shown, please use the link
below to view all information about this clinical trial. |
|
Click to view Full Listing
|